← Back to Search

Adapted Otago Exercise Program (OEP) for Peripheral Arterial Disease

N/A

Waitlist Available

Led By Siobhan K McMahon, PhD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial is testing whether adding a balance exercise component to existing supervised exercise therapy programs for people with peripheral artery disease (PAD) is an effective way to help reduce falls.

Eligible Conditions

Peripheral Arterial Disease
Falling.
Fall Injury

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Mini-Balance Evaluation Systems Test Score

Secondary outcome measures

Adherence to Home-Based Balance Exercises

Accidental Falls

Change in Life-Space Assessment (LSA) Score

+8 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Supervised Exercise Therapy (SET) Plus Balance ExercisesExperimental Treatment1 Intervention

Intervention meetings surrounding supervised exercise therapy (SET) with the addition of the adapted Otago Exercise Program (OEP) will occur individually with participants in a 1:1 format once per week for 30 minutes over 8 weeks. Additionally, participants will be encouraged to practice exercises at home at least 2 additional days between intervention meetings using visual handouts (up to 7 times/week total, approximately 140 minutes/week).

Group II: Supervised Exercise Therapy (SET) OnlyActive Control1 Intervention

Intervention meetings surrounding supervised exercise therapy (SET) will occur individually with participants in a 1:1 format once per week for 30 minutes over 8 weeks. Additionally, participants will be encouraged to practice exercises at home at least 2 additional days between intervention meetings using visual handouts (up to 7 times/week total, approximately 140 minutes/week).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Adapted Otago Exercise Program (OEP)

2021

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,378 Previous Clinical Trials

1,588,489 Total Patients Enrolled

8 Trials studying Peripheral Arterial Disease

1,271 Patients Enrolled for Peripheral Arterial Disease

Siobhan K McMahon, PhDPrincipal InvestigatorUniversity of Minnesota School of Nursing

2 Previous Clinical Trials

412 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrolment figure for this medical experiment?

"Affirmative. According to clinicaltrials.gov, this scientific investigation is still recruiting participants for its study; it was first posted on October 7th 2021 and the details have recently been updated on July 15th 2022. The research requires 20 volunteers from a single location."

Answered by AI

Is recruitment for this experiment still open?

"Clinicaltrials.gov suggests that this research trial is actively looking for participants, as the post was released on October 7th 2021 and recently updated on July 15th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Integrating Fall Prevention Balance Exercises Into a Program for Older Adults With Peripheral Artery Disease (PAD): A Mixed Methods Feasibility Study

2021. "Integrating Fall Prevention Balance Exercises Into a Program for Older Adults With Peripheral Artery Disease (PAD): A Mixed Methods Feasibility Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05090774.